TNF Pharmaceuticals Inc.
13F holders, Q1 2024 (March 31)19holders
$1.50avg. 13F price*
At the end of Q1 2024, 19 institutions reported holding TNF Pharmaceuticals Inc. in their 13F filings. The largest holders were Mirae Asset Global Investments Co., Ltd. ($1.3M), Vanguard Group Inc. ($73K) and BlackRock Inc. ($16K).
- Company
- TNF Pharmaceuticals Inc.
- Filed as
- MYMD PHARMACEUTICALS INC (Q1 2024)
- CUSIP
- 62856X201
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $81 |
| Exits | 0 | $0 |
Ownership 19 holders
| Mirae Asset Global Investments Co., Ltd. | 0.00% | Add +745.4% | 875,933 | $1.3M |
| Vanguard Group Inc. | 0.00% | Reduce -36.9% | 30,657 | $73K |
| BlackRock Inc. | 0.00% | Reduce -1.0% | 6,802 | $16K |
| UBS Group AG | 0.00% | Add +2342.0% | 2,022 | $5K |
| Parallel Advisors, LLC | 0.00% | No change | 838 | $2K |
| Group One Trading LLC | 0.00% | Reduce -0.6% | 459 | $1K |
| Osaic Holdings, Inc. | 0.00% | Add +15.6% | 266 | $634 |
| Morgan Stanley | 0.00% | Reduce -38.0% | 224 | $535 |
| Wells Fargo & Company | 0.00% | Add +1.0% | 177 | $423 |
| Sandy Spring Bank | 0.00% | Add +0.6% | 116 | $278 |
| Ancora Advisors LLC | 0.00% | No change | 90 | $215 |
| Harbor Investment Advisory, LLC | 0.00% | Add +1.3% | 90 | $215 |
| Arvest Investments, Inc. | 0.00% | Add +2.0% | 34 | $81 |
| NFSG Corp | 0.00% | Add +104.0% | 34 | $81 |
| WR Wealth Planners, LLC | 0.00% | New | 34 | $81 |
| Qube Research & Technologies Ltd | 0.00% | Add +36.4% | 3 | $7 |
| Cornerstone Planning Group LLC | 0.00% | Add +2900.0% | 1 | $4 |
| Bank of America Corp. | 0.00% | Reduce -49.1% | 1 | $2 |
| Royal Bank of Canada | 0.00% | Add +867.4% | 79 | $0 |
"% of holder's portfolio" is TNF PHARMACEUTICALS INC's weight in each manager's 13F, not the share of TNF Pharmaceuticals Inc. the manager owns.